October 23, 2025

Chest Pain & Shock After a Tuna Sandwich: What’s Your Diagnosis?

A 30-year-old man with no prior medical history developed cardiogenic shock shortly after eating a tuna sandwich. He experienced central, burning chest pain, diaphoresis, and generalized pruritus. His pain worsened with breathing and did not respond to nitroglycerin.

Conexiant

October 22, 2025

FDA Redefining Depression Treatment with New Approvals?

Researchers analyze FDA-approved and Phase 3 antidepressants from 2009 to 2025.

Conexiant

October 20, 2025

Obinutuzumab Wins FDA Nod for Lupus Nephritis

Roche's anti-CD20 antibody improved renal response and allowed for lower corticosteroid use in the phase III REGENCY trial, offering a twice-yearly maintenance option after initial dosing.

Conexiant

October 17, 2025

FDA Awards Nine CNPV Vouchers to Speed Reviews

Pilot aims to expedite access to high‑impact therapies by streamlining FDA review and strengthening sponsor–agency collaboration.

Conexiant

October 16, 2025

HHS Memo: Fringe Finds a Footing

From wheat fields to Washington: a decades-old fear about skies and 'sprays' rises again, colliding with science, social media, and the machinery of federal policymaking.

KFF Health News

October 10, 2025

Adolescent and Adult VTE After Arthroscopy Compared in Study

Lower venous thromboembolism risk is shown in adolescents than adults after knee arthroscopy, but comorbidities like diabetes and obesity raise risk.

Conexiant

October 09, 2025

Is Science Retracting Enough Papers?

As paper mills and fraud proliferate, experts warn the retraction rate should reach 2% of published literature—ten times current levels.

Conexiant

October 07, 2025

FDA Announces New Development in Lung Care

The FDA has approved the first treatment in more than a decade for idiopathic pulmonary fibrosis.

Conexiant

October 06, 2025

Sarcopenia Prevalence Reported in Advanced Lung Disease, Study

Researchers evaluate sarcopenia definitions and tools in patients with lung disease.

Conexiant